• Myxomatous degeneration. Often occurring in elderly patients, this is a common cause of valvular regurgitation. It involves a weakening of valve tissue as a result of metabolic changes in the valve, resulting in a loss of tissue elasticity and strength.

  • Rheumatic fever. About 65 percent of rheumatic fever patients develop some form of valvular heart disease, though its overall occurrence has decreased due to the widespread use of antibiotics.

  • High blood pressure (hypertension)

  • heart failure

  • Coronary artery disease. Due to dilation of the heart or involvement of the muscle regulating the valve function (papilary muscle)

  • Pulmonary hypertension (in the case of tricuspid regurgitation)

  • Atherosclerosis

  • An inflammation or infection of the valve (endocarditis)

  • Genetic connective tissue disorders, such as Marfan syndrome

  • Family history of the above

  • Use of diet pills containing phentermine, fenfluramine and/or dexfenfluramine (e.g., fen-phen). The U.S. Food and Drug Administration (FDA) removed fen-phen from the market in 1997.

  • Systemic lupus erythematosus, sarcoidosis

  • Other valve conditions, such as mitral valve prolapse